Using this MS model, we established that HGF exerts an anti-inflammatory effect through the generation of tolerogenic DCs and the subsequent suppression of autoreactive peripheral Th1 and Th17 cells, leading to reduced CD4+ T cell-mediated CNS injury. This evidence concerns the gene CD4 and myeloid sarcoma.